TWP-20872-05826
4 vaccinations
1 coded response
36 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 972 / OR
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Registered in v-safe
-
2021-01-23
Dose 1 — Moderna
- 2021-01-23
- 2021-01-24
- 2021-01-26
- 2021-01-28
- 2021-01-29
- 2021-02-01
- 2021-02-06
- 2021-02-13
- 2021-02-22
-
2021-02-24
Dose 2 — Moderna
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-05-26
-
2021-10-26
Dose 3 — Pfizer-BioNTech
-
2023-02-17
Dose 4 — Pfizer-BioNTech
- 2023-02-17
-
2023-02-18
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
- 2023-02-19
- 2023-02-20
- 2023-02-21
- 2023-02-22
- 2023-02-23
- 2023-02-24
- 2023-03-03
- 2023-03-12
- 2023-03-17
- 2023-03-24
- 2023-04-02
-
2023-05-21
Survey response — 3 months, dose 4MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Moderna | |
| 2 | 2021-02-24 | Moderna | |
| 3 | 2021-10-26 | Pfizer-BioNTech | No |
| 4 | 2023-02-17 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release